Pediatric Clinical Trials

No data was found
Disease Type
Diagnosis Type
Status
Filter by disease/Status
BH-P-FLOAT
A Phase I/II, First-in-human, Open-label Trial of the Safety, Efficacy, Tolerability, Pharmacokinetics, and Immunogenicity of BNT317 in Participants With Advanced Solid Tumors
Protocol Status: OPEN TO ACCRUAL
Trial Type: Basket Trials
Contact: Carneiro, Benedito
benedito.carneiro@BrownHealth.org
BH-P-TROPION-TU03
A Randomized, Open-Label, Phase 2/3 Study of Datopotamab Deruxtecan (Dato-DXd) Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC) Who Progressed During or After Enfortumab Vedotin (EV) Plus Pembrolizumab Combination Treatment TROPION-Urothelial03 (TU03)
Protocol Status: OPEN TO ACCRUAL
Trial Type: Genitourinary, Other Urinary, Urinary Bladder
Contact: Lagos, Galina
GLagos@BrownHealth.org
BH-P-PRISM
A Pivotal Phase 2/3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Adaptive Design Study of L Annamycin for Injection in Combination With Cytarabine Injection Versus Placebo in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed Acute Myeloid Leukemia
Protocol Status: OPEN TO ACCRUAL
Trial Type: Leukemia, Myeloid and Monocytic Leukemia
Contact: Reagan, John
jreagan@BrownHealth.org